En Es
Categories

Industry News

Blood Testing Market Surpasses USD 2 Billion in 2016

By Labmedica International staff writers
16 Jun 2017

Image: The global market for blood testing and typing products reached USD 2.6 billion in 2016 (Photo courtesy of iStock).The global market for blood testing and typing products used in blood banking/donations of pooled blood reached USD 2.6 billion in 2016, although blood banking is not a fast-growing market and tends to grow only when new diseases are added to testing menu. These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

In its study of the testing markets amidst increased vigilance by U.S. health authorities and cases of Zika and other diseases, Kalorama found three common types of tests related to blood banking:

Immunoassays for HIV, hepatitis B, hepatitis C and syphilis are routinely used to test blood units for blood borne infectious agents. In Latin America, all blood banks also screen donated units for Chagas disease while in some developing countries, blood banks undertake additional screening for Dengue fever and malaria, which are common and deadly in several tropical nations.

Blood grouping and typing reagents and instruments are used by blood transfusion services, hospital and private blood banks and hospital laboratories that prepare blood units for transfusion to patients. Blood bank lab systems require blood tracking to avoid the possibility of the serious error of administering the wrong blood type to a patient.

Nucleic acid testing (NAT) allows blood banks to detect viral contamination, including West Nile Virus, HIV and hepatitis C, sooner and stop them from slipping into blood transfusions, thus making NAT an integral part of efforts to make blood transfusions safer. An estimated 53 million units of blood are screened using NAT. The commonly used NAT assays detect HIV-1 RNA, HCV RNA, HBV DNA, and West Nile Virus (WNV) RNA, and are used to test for West Nile virus, HIV and HCV in almost all the blood drawn in North America, Europe and Japan.

“Although no dramatic change in the testing industry is expected, new guidelines and disease concerns make it a worthwhile time for business planners to revisit test market assumptions,” said Bruce Carlson, Publisher of Kalorama Information.

Related Links:
Kalorama Information



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

12 Dec 2017
TeraRecon to Sell EnvoyAI Platform
TeraRecon, a provider of advanced visualization solutions, has entered into a distribution partnership with EnvoyAI to sell and market the EnvoyAI platform. The platform includes a content-rich artificial intelligence (AI) marketplace, called the EnvoyAI Exchange, as well as a suite of market-ready AI-enablement technologies aimed at fostering broader access and clinical use of medical imaging algorithms within busy radiology practices.
Read More
12 Dec 2017
Google Releases AI Tool for Precision Medicine
Google LLC has announced the open source release of DeepVariant, a deep learning technology to reconstruct the true genome sequence from high-throughput sequencing (HTS) data with significantly greater accuracy than previous classical methods. DeepVariant, which was developed after more than two years of research by the Google Brain team, in collaboration with Verily Life Sciences, transforms the task of variant calling, as this reconstruction problem is known in genomics, into an image classification problem well-suited to Google's existing technology and expertise. Within a year of its development, the deep learning model had won the 2016 PrecisionFDA Truth Challenge award for Highest SNP Performance, outperforming state-of-the-art methods. Since then, the Google Brain team has reduced the error rate by over 50%.
Read More
11 Dec 2017
Esaote to Be Acquired by Consortium of Chinese Healthcare Companies
Esaote S.p.A. has entered into definitive agreements with a consortium of Chinese investors who will acquire the entire share capital of the company. The consortium acquiring Esaote comprises leading medical technology and healthcare companies, as well as financial investors with significant experience in the healthcare sector.
Read More
06 Dec 2017
Global Hybrid OR Market to Reach USD 1,17 Million by 2022
The global hybrid operating room (OR) market is expected to grow at a CAGR of 12.5% from USD 652.0 million in 2017 to USD 1,174.9 million by 2022, driven by technological advancements in robot-assisted surgeries, increasing minimally invasive surgeries, and growing patient preference for affordable & effective surgical treatments. However, high establishment costs and procedural risks for patients associated with hybrid ORs are expected to limit the market growth during 2017 to 2022.
Read More
06 Dec 2017
Siemens to List Siemens Healthineers on Frankfurt Stock Exchange
Siemens AG, a provider of medical imaging and laboratory diagnostics equipment, is preparing to list its separately managed healthcare unit, Siemens Healthineers, on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market. The move was approved at a meeting by the company's Supervisory Board and has been planned for the first half of 2018. Siemens Healthineers AG will be established for the public listing.
Read More
06 Dec 2017
GE Healthcare and Nuance Partner with NVIDIA to Bring AI to Medical Imaging
Healthcare-solution providers GE Healthcare and Nuance Communications, Inc., have partnered with NVIDIA, a leader in visual computing technologies, for using the company’s deep learning platform to bring Artificial Intelligence (AI) to medical imaging.
Read More
06 Dec 2017
Neuroimaging Platform Uses 3D AI to Offer Brain Visualization
QMENTA, a medical image storage, processing and visualization company focused on brain data analysis, specifically using MRI and related clinical data, has developed a cloud-based system for neuroimages and all related data, with data management, analysis and visualization capabilities.
Read More
05 Dec 2017
GE Launches Drawbridge Health to Transform Blood Collection
GE Healthcare has introduced Drawbridge Health, a privately held healthcare technology company, which is developing a people-friendly system to integrate draw, collection and stabilize blood samples into a single device. The technology which integrates engineering and proprietary chemistries is also being developed to support room temperature shipping and streamlined downstream processing, thus ensuring reliable, accurate results.
Read More
29 Nov 2017
CE Mark Awarded to First Commercial Head And Neck Deep Learning Solution
The world's first commercial head and neck deep learning medical imaging solution from Aidoc, an AI startup utilizing deep learning to augment radiologists' workflow and highlight anomalous cases, has received CE (Conformité Européenne) marking, allowing for its widespread commercialization in Europe.
Read More
Copyright © 2000-2017 TradeMed.com. All rights reserved. | Terms And Conditions